IT1203968B - Complessi di b-ciclodestrina ad attivita' antimicotica - Google Patents

Complessi di b-ciclodestrina ad attivita' antimicotica

Info

Publication number
IT1203968B
IT1203968B IT20256/87A IT2025687A IT1203968B IT 1203968 B IT1203968 B IT 1203968B IT 20256/87 A IT20256/87 A IT 20256/87A IT 2025687 A IT2025687 A IT 2025687A IT 1203968 B IT1203968 B IT 1203968B
Authority
IT
Italy
Prior art keywords
cyclodestrine
complexes
fungal activities
fungal
activities
Prior art date
Application number
IT20256/87A
Other languages
English (en)
Other versions
IT8720256A0 (it
Inventor
Loris Jacobo Bononi
Original Assignee
Bononi Ricerca
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bononi Ricerca filed Critical Bononi Ricerca
Priority to IT20256/87A priority Critical patent/IT1203968B/it
Publication of IT8720256A0 publication Critical patent/IT8720256A0/it
Priority to DE8888106260T priority patent/DE3874941T2/de
Priority to EP88106260A priority patent/EP0288019B1/en
Priority to JP63099353A priority patent/JP2720929B2/ja
Priority to KR1019880004742A priority patent/KR970004051B1/ko
Application granted granted Critical
Publication of IT1203968B publication Critical patent/IT1203968B/it
Priority to US07/579,084 priority patent/US5422347A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Oncology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT20256/87A 1987-04-24 1987-04-24 Complessi di b-ciclodestrina ad attivita' antimicotica IT1203968B (it)

Priority Applications (6)

Application Number Priority Date Filing Date Title
IT20256/87A IT1203968B (it) 1987-04-24 1987-04-24 Complessi di b-ciclodestrina ad attivita' antimicotica
DE8888106260T DE3874941T2 (de) 1987-04-24 1988-04-20 Beta-zyklodextrin-komplexe mit antimykotieker aktivitaet.
EP88106260A EP0288019B1 (en) 1987-04-24 1988-04-20 Beta-cyclodextrin complexes having anti-mycotic activity
JP63099353A JP2720929B2 (ja) 1987-04-24 1988-04-23 抗真菌活性を有するβ−シクロデキストリンの錯体
KR1019880004742A KR970004051B1 (ko) 1987-04-24 1988-04-25 항-진균활성도를 가지는 β-시클로 덱스트린 착염
US07/579,084 US5422347A (en) 1987-04-24 1990-09-05 β-cyclodextrin complexes of miconazole and econazole

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT20256/87A IT1203968B (it) 1987-04-24 1987-04-24 Complessi di b-ciclodestrina ad attivita' antimicotica

Publications (2)

Publication Number Publication Date
IT8720256A0 IT8720256A0 (it) 1987-04-24
IT1203968B true IT1203968B (it) 1989-02-23

Family

ID=11165196

Family Applications (1)

Application Number Title Priority Date Filing Date
IT20256/87A IT1203968B (it) 1987-04-24 1987-04-24 Complessi di b-ciclodestrina ad attivita' antimicotica

Country Status (6)

Country Link
US (1) US5422347A (it)
EP (1) EP0288019B1 (it)
JP (1) JP2720929B2 (it)
KR (1) KR970004051B1 (it)
DE (1) DE3874941T2 (it)
IT (1) IT1203968B (it)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1067639A (ja) * 1996-08-26 1998-03-10 Shiseido Co Ltd ビタミンe−ビタミンcリン酸ジエステル/シクロデキストリン包接物及び該包接物を配合した皮膚外用剤
US6824763B2 (en) 2002-05-30 2004-11-30 Kimberly-Clark Worldwide, Inc. Anti-fungal powder having enhanced excipient properties
CA2735460A1 (en) * 2008-08-29 2010-03-04 The Uab Research Foundation Novel anti-arrhythmia agent
US10426744B2 (en) * 2016-04-08 2019-10-01 Harrow Health, Inc. Anti-fungal compositions for treating nails and methods for fabricating and using thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3459731A (en) * 1966-12-16 1969-08-05 Corn Products Co Cyclodextrin polyethers and their production
US3453259A (en) * 1967-03-22 1969-07-01 Corn Products Co Cyclodextrin polyol ethers and their oxidation products
DE3346123A1 (de) * 1983-12-21 1985-06-27 Janssen Pharmaceutica, N.V., Beerse Pharmazeutische praeparate von in wasser schwerloeslichen oder instabilen arzneistoffen und verfahren zu ihrer herstellung
GB8506792D0 (en) * 1985-03-15 1985-04-17 Janssen Pharmaceutica Nv Derivatives of y-cyclodextrin

Also Published As

Publication number Publication date
EP0288019B1 (en) 1992-09-30
IT8720256A0 (it) 1987-04-24
DE3874941D1 (de) 1992-11-05
DE3874941T2 (de) 1993-02-18
US5422347A (en) 1995-06-06
KR970004051B1 (ko) 1997-03-24
EP0288019A1 (en) 1988-10-26
KR880012645A (ko) 1988-11-28
JPS6425766A (en) 1989-01-27
JP2720929B2 (ja) 1998-03-04

Similar Documents

Publication Publication Date Title
FI883596A0 (fi) Epipodofyllotoxinglukosid-4' -fosfatderivat.
DE69013029D1 (de) Reissverschluss.
DE69005708D1 (de) Reissverschluss.
FI880405A0 (fi) Adenosin-5'-karboxamidderivat.
FI890611L (fi) 3'-deamino-4'-deoxi-4'-amino -antracykliner.
DE69013951D1 (de) Reissverschluss.
IT8919029A0 (it) Composti ad attivita' antiserotoninica.
IT8721063A0 (it) Composizione ad attivita'tricogena.
IT8819464A0 (it) Indumento di protezione.
NO883857L (no) 3'-demetoksyepipodofyllotoksin-glukosidderivater.
FI885785A0 (fi) Epipodofyllotoxinglukosid-4' -acylderivat.
DE69008573D1 (de) Reissverschluss.
IT9022047A0 (it) 13-desosso-4'-desossi-4'-iodoantracicline
FR2605435B3 (fr) Panneau d'affichage
IT8621194A0 (it) Azolilderivati ad attivita'antifungina.
IT1188653B (it) Cianoacetoammido-derivati ad azione antifungina
IT8720256A0 (it) Complessi di b- ciclodestrina adattivita' antimicotica.
IT1215550B (it) Benzoil-uree ad attivita'insetticida
IT1226838B (it) Macinacaffe'.
IT8821613A0 (it) Cerniera agganciabile.
IT1222074B (it) Composizione ad attivita' antiforfora
NO873728D0 (no) Sekstenskafts tolagsvevnad.
SE8700965D0 (sv) "varmslaktemballering"
SE8704273D0 (sv) "kaffepasen"
SE8703558D0 (sv) "varmslaktemballering"